Navigation Links
Obama’s Bioethics Commission to meet in D.C.
Date:7/27/2012

WASHINGTON, D.C. The Presidential Commission for the Study of Bioethical Issues will hold its tenth public meeting on August 1-2, 2012.

The Commission will continue its work in the following areas:

Genomics and Privacy:

Since January 2011 the Commission has been following the pressing problems raised by the emergence of whole genome sequencing as an addition to clinical care and genetic research. The Commission's genomics project seeks to outline many of the key issues surrounding how to reconcile an individual's need for privacy, consent, and respect with the need for gathering data from many individuals to advance discoveries to benefit the common good.

At this meeting the Commission will hear from speakers on a range of topics related to the privacy of and access to genomic data. For example, Latanya Sweeney, Ph.D. of Harvard University and Sonia Suter, M.S., J.D. of George Washington University will discuss how technology is changing views of genomic privacy; and Ken Chahine, Ph.D., J.D. of Ancestry, DNA and Laura Lyman Rodriguez, Ph.D. of the National Human Genome Research Institute will present on the protection of private and public genomic databases.

There will be substantial Member discussion and deliberation as this is the last meeting before the Commission releases its report with recommendations. The Commission expects to deliver a report on genomics and privacy in fall 2012.

Medical Countermeasures for Children:

At the request of Health and Human Services Secretary Kathleen Sebelius, the Commission is conducting a careful and transparent review of the ethical considerations of conducting clinical trials of medical countermeasures with children. The Commission is examining whether the U.S. government should do research that could cause harm to protect children from high consequence events with a low or unknown likelihood of happening. The Commission's report will include the ethical considerations of conducting a pre- and post-event study of an anthrax vaccine as a component of treatment for children exposed to weaponized anthrax.

The Commission will hear from subject matter experts including: David Resnik, J.D., Ph.D. of the NIH, Neal Halsey, M.D. of the Johns Hopkins School of Medicine, and Ruth Berkelman, M.D. of Emory University on the topic of considering individual risk versus Societal Benefit in assessing pediatric research. In addition, the Commission will hear from Paul B. Thompson, Ph.D. of Michigan State University, Richard Gorman, M.D. from the HHS Office of the Assistant Secretary for Preparedness and Response, and from Thomas A. Moore, M.D., F.A.C.P., Chair of the FDA Anti-Infective Drug Advisory Committee about what scientific, medical, and public health information is needed to facilitate decision-making for pediatric research on medical countermeasures.


'/>"/>

Contact: Hillary Wicai Viers
Hillary.Viers@bioethics.gov
202-233-3960
Presidential Commission for the Study of Bioethical Issues
Source:Eurekalert

Related biology news :

1. Synthetic Biology Scorecard finds federal agencies responding to bioethics report
2. Bioethics for Beginners: 60 Cases and Cautions from the Moral Frontier of Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... Prairie, WI (PRWEB) , ... June 23, 2016 ... ... consultancy focused on quality, regulatory and technical consulting, provides a free webinar ... is presented on July 13, 2016 at 12pm CT at no charge. , ...
Breaking Biology Technology: